Enzo Bonora Selected Research

Enzo Bonora Research Topics

Disease

52	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2002
29	Insulin Resistance 01/2022 - 07/2002
15	Hypertension (High Blood Pressure) 01/2020 - 07/2002
10	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 07/2002
9	Albuminuria 05/2021 - 09/2009
9	Chronic Renal Insufficiency 01/2020 - 05/2011
8	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 10/2009
8	Body Weight (Weight, Body) 01/2022 - 08/2017
8	Non-alcoholic Fatty Liver Disease 10/2018 - 10/2010
7	Obesity 01/2022 - 07/2004
5	Weight Loss (Weight Reduction) 01/2022 - 10/2015
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2017 - 04/2003
5	Inflammation (Inflammations) 01/2017 - 01/2006
5	Dyslipidemias (Dyslipidemia) 12/2016 - 07/2004
4	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 02/2002
4	Hypoglycemia (Reactive Hypoglycemia) 06/2019 - 04/2016
4	Diabetes Mellitus 01/2019 - 08/2013
4	Myocardial Ischemia (Ischemic Heart Diseases) 12/2017 - 12/2016
3	Myocardial Infarction 01/2019 - 08/2012
3	Hypercholesterolemia 05/2017 - 01/2014
3	Overweight 01/2016 - 07/2004
3	Atherosclerosis 06/2015 - 07/2002
2	Hyperandrogenism 01/2022 - 02/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 11/2016
2	Abdominal Obesity 12/2019 - 04/2008
2	Hyperglycemia 01/2019 - 07/2004
2	Hypothyroidism 10/2018 - 10/2009
2	Diabetic Foot 01/2018 - 01/2018
2	Ulcer 01/2018 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2017 - 09/2013
2	Atrial Fibrillation 12/2017 - 01/2017
2	Heart Block 12/2017 - 01/2017
2	Heart Valve Diseases (Valvular Heart Disease) 12/2017 - 09/2013
2	Atherosclerotic Plaque (Atheroma) 05/2017 - 06/2016
2	Heart Failure 04/2016 - 09/2013
2	Donohue Syndrome 12/2013 - 03/2008
2	Renal Insufficiency (Renal Failure) 08/2013 - 08/2013
2	Hyperuricemia 01/2012 - 11/2008
2	Glucose Intolerance 07/2004 - 07/2002
1	Morbid Obesity 01/2022
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2022
1	Vomiting 10/2021
1	Diarrhea 10/2021
1	Nausea 10/2021
1	Weight Gain 10/2021
1	Insulinoma 01/2019
1	Acute Coronary Syndrome 01/2019
1	Margins of Excision 01/2019

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2002
20	Insulin (Novolin)FDA Link 01/2022 - 02/2002
12	Hemoglobins (Hemoglobin)IBA 01/2020 - 06/2010
11	HDL CholesterolIBA 01/2021 - 01/2006
11	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2006
11	LipidsIBA 10/2020 - 07/2002
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 04/2011
7	AndrogensIBA 01/2022 - 05/2012
7	CholesterolIBA 01/2021 - 07/2002
7	CreatinineIBA 10/2020 - 09/2011
6	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 08/2013
6	LDL CholesterolIBA 01/2021 - 02/2007
6	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 09/2009
5	dulaglutideIBA 12/2021 - 01/2021
5	Antihypertensive Agents (Antihypertensives)IBA 08/2012 - 09/2009
4	Testosterone (Sustanon)FDA Link 01/2022 - 05/2012
4	C-PeptideIBA 01/2020 - 03/2008
4	Uric Acid (Urate)IBA 12/2017 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2006
3	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2019 - 04/2016
3	Pioglitazone (Actos)FDA Link 01/2019 - 12/2012
3	C-Reactive ProteinIBA 11/2018 - 02/2007
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2017 - 02/2007
3	oxidized low density lipoproteinIBA 01/2014 - 01/2006
3	Hemoglobin AIBA 03/2012 - 10/2010
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2018
2	Liraglutide FDA Link 01/2022 - 11/2016
2	Exenatide (Byetta)FDA Link 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2016
2	Biological ProductsIBA 01/2018 - 01/2013
2	empagliflozinIBA 08/2017 - 11/2016
2	Vitamin D FDA LinkGeneric 01/2015 - 01/2013
2	Hemostatics (Antihemorrhagics)IBA 07/2014 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 03/2014 - 03/2008
2	Fibrinogen (Factor I)FDA Link 01/2014 - 02/2007
2	PotassiumIBA 12/2013 - 03/2008
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2012 - 09/2009
2	Oxidants (Oxidizing Agents)IBA 01/2008 - 02/2002
1	Hormones (Hormone)IBA 01/2022
1	semaglutideIBA 01/2022
1	HDL-triglycerideIBA 01/2021
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 11/2020
1	SubtilisinIBA 11/2020
1	Zinc Transporter 8IBA 11/2019
1	Edotreotide (SMT 487)IBA 01/2019

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2012
4	Glycemic Control 01/2022 - 10/2015
3	Bariatric Surgery 01/2021 - 10/2015
3	Resistance Training 01/2019 - 04/2012
2	Blood Component Removal (Apheresis) 11/2018 - 01/2014
1	Pancreatectomy 01/2019